FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220797643> ?p ?o ?g. }

• W4220797643 abstract "Background: Epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs) combined with chemotherapy in patients with RAS (rat sarcoma viral oncogene homolog) wild-type metastatic colorectal cancer (mCRC) can alleviate and stabilize the disease, effectively prolong the progression-free survival (PFS) and overall survival (OS), and improve the overall response rate (ORR), which is the first-line treatment standard scheme for RAS wild-type mCRC currently. However, whether anti-EGFR mAb can be used for the maintenance treatment after the first-line treatment of mCRC remains controversial. We reviewed the recent studies on anti-EGFR mAb. The contents include five parts, introduction, anti-EGFR mAb in mCRC and its status in first-line therapy, establishment of the maintenance treatment pattern after the standard first-line treatment for mCRC, research progress of anti-EGFR mAb in mCRC maintenance therapy, and conclusion. More studies support the maintenance treatment of anti-EGFR mAb, but some researchers raise the problems about high cost and drug resistance. Despite lack of the maintenance evidence of anti-EGFR mAb, especially lack of large-scale phase III prospective clinical trials, with the emergence of new evidence and more accurate screening of treatment-dominant groups, maintenance therapy with anti-EGFR mAb monotherapy or anti-EGFR mAb combined with fluorouracil-based schemes after first-line chemotherapy combined with anti-EGFR mAb therapy might strive for more treatment opportunities, optimize treatment strategies and prolong treatment continuity, and finally, lead to more survival benefit for suitable patients." @default.
• W4220797643 created "2022-04-03" @default.
• W4220797643 creator A5009579813 @default.
• W4220797643 creator A5045553246 @default.
• W4220797643 creator A5070620244 @default.
• W4220797643 creator A5086197105 @default.
• W4220797643 date "2022-03-30" @default.
• W4220797643 modified "2023-10-14" @default.
• W4220797643 title "The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy" @default.
• W4220797643 cites W1871216091 @default.
• W4220797643 cites W1974024530 @default.
• W4220797643 cites W1974365898 @default.
• W4220797643 cites W1995242599 @default.
• W4220797643 cites W2005348280 @default.
• W4220797643 cites W2006022204 @default.
• W4220797643 cites W2013384278 @default.
• W4220797643 cites W2015869041 @default.
• W4220797643 cites W2048733292 @default.
• W4220797643 cites W2060481216 @default.
• W4220797643 cites W2085633477 @default.
• W4220797643 cites W2095201384 @default.
• W4220797643 cites W2098354753 @default.
• W4220797643 cites W2103856575 @default.
• W4220797643 cites W2106789440 @default.
• W4220797643 cites W2108235590 @default.
• W4220797643 cites W2109498035 @default.
• W4220797643 cites W2111031611 @default.
• W4220797643 cites W2120921373 @default.
• W4220797643 cites W2124451268 @default.
• W4220797643 cites W2126573891 @default.
• W4220797643 cites W2127941773 @default.
• W4220797643 cites W2129255527 @default.
• W4220797643 cites W2134142320 @default.
• W4220797643 cites W2134519717 @default.
• W4220797643 cites W2137417501 @default.
• W4220797643 cites W2144690940 @default.
• W4220797643 cites W2144798655 @default.
• W4220797643 cites W2145070131 @default.
• W4220797643 cites W2153211112 @default.
• W4220797643 cites W2161097769 @default.
• W4220797643 cites W2227477053 @default.
• W4220797643 cites W2235021622 @default.
• W4220797643 cites W2279724365 @default.
• W4220797643 cites W2336217205 @default.
• W4220797643 cites W2509067245 @default.
• W4220797643 cites W2543824287 @default.
• W4220797643 cites W2758868699 @default.
• W4220797643 cites W2769280723 @default.
• W4220797643 cites W2775469584 @default.
• W4220797643 cites W2787981425 @default.
• W4220797643 cites W2788375477 @default.
• W4220797643 cites W2883565202 @default.
• W4220797643 cites W2892347132 @default.
• W4220797643 cites W2954681275 @default.
• W4220797643 cites W2969350423 @default.
• W4220797643 cites W2969800158 @default.
• W4220797643 cites W2995315963 @default.
• W4220797643 cites W2999417355 @default.
• W4220797643 cites W3005197357 @default.
• W4220797643 cites W3018807354 @default.
• W4220797643 cites W3043068629 @default.
• W4220797643 cites W3123738613 @default.
• W4220797643 cites W3124225884 @default.
• W4220797643 cites W3134887329 @default.
• W4220797643 cites W3191292273 @default.
• W4220797643 cites W3208855266 @default.
• W4220797643 cites W4226248999 @default.
• W4220797643 cites W51995314 @default.
• W4220797643 doi "https://doi.org/10.3389/fmolb.2022.870395" @default.
• W4220797643 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35433839" @default.
• W4220797643 hasPublicationYear "2022" @default.
• W4220797643 type Work @default.
• W4220797643 citedByCount "4" @default.
• W4220797643 countsByYear W42207976432022 @default.
• W4220797643 countsByYear W42207976432023 @default.
• W4220797643 crossrefType "journal-article" @default.
• W4220797643 hasAuthorship W4220797643A5009579813 @default.
• W4220797643 hasAuthorship W4220797643A5045553246 @default.
• W4220797643 hasAuthorship W4220797643A5070620244 @default.
• W4220797643 hasAuthorship W4220797643A5086197105 @default.
• W4220797643 hasBestOaLocation W42207976431 @default.
• W4220797643 hasConcept C121608353 @default.
• W4220797643 hasConcept C126322002 @default.
• W4220797643 hasConcept C143998085 @default.
• W4220797643 hasConcept C159654299 @default.
• W4220797643 hasConcept C203014093 @default.
• W4220797643 hasConcept C2776694085 @default.
• W4220797643 hasConcept C2776999253 @default.
• W4220797643 hasConcept C2777506169 @default.
• W4220797643 hasConcept C2778283404 @default.
• W4220797643 hasConcept C2778332735 @default.
• W4220797643 hasConcept C2779438470 @default.
• W4220797643 hasConcept C2779998722 @default.
• W4220797643 hasConcept C526805850 @default.
• W4220797643 hasConcept C542903549 @default.
• W4220797643 hasConcept C71924100 @default.
• W4220797643 hasConceptScore W4220797643C121608353 @default.
• W4220797643 hasConceptScore W4220797643C126322002 @default.
• W4220797643 hasConceptScore W4220797643C143998085 @default.
• W4220797643 hasConceptScore W4220797643C159654299 @default.

• next